Savara’s Aironite shows treatment effect in mid-stage pulmonary hypertension study; shares ahead 4% Seeking Alpha By John Harbison|2017-07-11T12:07:42-08:00July 11, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Savara’s Aironite shows treatment effect in mid-stage pulmonary hypertension study; shares ahead 4% Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
